© Newsfile
11.02.2025
COPN
LISTED
SIX
Cosmo Appoints Andrea Cherubini as Chief AI Officer to Drive AI Expansion Across Portfolio
News Preview
Dublin, Ireland--(Newsfile Corp. - February 11, 2025) - Planet Friendly Technologies, Inc.Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced the appointment of Andrea Cherubini as Chief AI Officer effective immediately. This important decision reflects Cosmo’s commitment to integrating Artificial Inte...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
NSIS B
LISTED
CPH
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
News Preview
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5 billion. After more than 25 years of successful collaboration, a strategic repositioning at dsm-firmenich allowed this opportunity to materialize. This...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
NSIS B
LISTED
CPH
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
News Preview
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5 billion. After more than 25 years of successful collaboration, a strategic repositioning at dsm-firmenich allowed this opportunity to materialize. This...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
11.02.2025
HELP
LISTED
NASDAQ
Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today reported unaudited financial results for its third quarter ended December 31, 2024, and rece...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
10.02.2025
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
News Preview
Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.02.2025
MRK
LISTED
XETR
Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition
News Preview
Darmstadt, February 10, 2025 – Merck KGaA (“Merck”) reacts to press reports and confirms advanced discussions with Springworks Therapeutics, Inc. Merck also confirms that no legally binding agreement has been entered into. There is no certainty that any transaction will materialize. Furthermore, critical conditions have yet to be met.
End of insid......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.02.2025
MRK
LISTED
XETR
Merck KGaA bestätigt Gespräche mit Springworks Therapeutics, Inc. zu möglicher Übernahme
News Preview
Darmstadt, 10. Februar 2025 - Merck KGaA („Merck“) reagiert auf Presseberichte und bestätigt fortgeschrittene Gespräche mit Springworks Therapeutics, Inc. Merck bestätigt auch, dass keine rechtlich bindende Vereinbarung getroffen wurde. Es gibt keine Gewissheit, dass eine Transaktion zustande kommen wird. Außerdem müssen noch kritische Bedingungen ......
Themefolio
Profiler
Peergroup
© Globe Newswire
10.02.2025
CHEMM
LISTED
CPH
Notification of managers' transactions
News Preview
ANNOUNCEMENT NO. 288...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.02.2025
AGFB
LISTED
EURONEXT
An Incredible KLAS Triple-Award Win for AGFA HealthCare!
News Preview
MORTSEL, BE / ACCESS Newswire / February 10, 2025 / AGFA HealthCare proudly celebrates a remarkable KLAS triple-win, securing two #1 Best in KLAS Awards for XERO® Viewer and VNA, alongside the KLAS Most Improved Software Product for 2025."To receive a KLAS Award is one of the most notable wins for AGFA HealthCare, and a testament to the h...
Themefolio
Profiler
Peergroup
© Newsfile
10.02.2025
COPN
LISTED
SIX
Cosmo and Glenmark Announces UK MHRA Approval of Winlevi(R) for Treatment of Acne
News Preview
Dublin, Ireland, and Mumbai, India and London, United Kingdom--(Newsfile Corp. - February 10, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) and Glenmark Pharmaceuticals Limited (Glenmark), a global research-led pharmaceutical company, today announced that Glenmark had received approval from the Medicines...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.02.2025
GNFT
LISTED
EURONEXT
GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 10, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the final terms of the 2025 OCEANEs repurchase proposal and the consent fee th...
Themefolio
Profiler
Peergroup
© EQS Newswire
07.02.2025
GXI
LISTED
XETR
Gerresheimer AG confirms discussions with private equity investors on potential takeover offer
News Preview
Gerresheimer AG confirms discussions with private equity investors on potential takeover offer
Düsseldorf, February 7, 2025 – The Executive Board of Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer") reacts to press reports and confirms that Gerresheimer is in early-stage discussions with private equity investors who have expressed, on an infor......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
07.02.2025
GXI
LISTED
XETR
Gerresheimer AG bestätigt Diskussionen mit Private Equity Investoren über mögliches Übernahmeangebot
News Preview
Gerresheimer AG bestätigt Diskussionen mit Private Equity Investoren über mögliches Übernahmeangebot
Düsseldorf, 7. Februar 2025 – Der Vorstand der Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer") reagiert auf Presseberichte und bestätigt, dass sich Gerresheimer in ersten Diskussionen mit Private Equity Investoren befindet, die gegenüber dem V......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.02.2025
DIM
LISTED
EURONEXT
Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting
News Preview
Sartorius Stedim Biotech SA
/ Key word(s): Dividend
Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting 07-Feb-2025 / 15:57 CET/CEST
Aubagne, February 7, 2025Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euro......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.02.2025
SRT3
LISTED
XETR
Aufsichtsrat der Sartorius AG schlägt Dividende in Höhe von 0,74 Euro je Vorzugsaktie vor
News Preview
Göttingen, 7. Februar 2025
Aufsichtsrat der Sartorius AG schlägt Dividende
in Höhe von 0,74 Euro je Vorzugsaktie vor
Der Aufsichtsrat der Sartorius AG hat in seiner heutigen Sitzung der Empfehlung des Vorstands zugestimmt, der Hauptversammlung am 27. März 2025 für das Geschäftsjahr 2024 eine Dividende in Höhe des Vorjahres von 0,74 Euro je Vorzug......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.02.2025
SRT3
LISTED
XETR
The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
News Preview
Göttingen, February 7, 2025
The Supervisory Board of Sartorius AG proposes
a dividend of 0.74 euros per preference share
The Supervisory Board of Sartorius AG resolved at its meeting today to approve the recommendation of the Executive Board to submit a proposal to the Annual General Meeting on March 27, 2025, to pay a dividend of 0.74 euros p......
Themefolio
Profiler
Peergroup
© PR Newswire
07.02.2025
DEDI
LISTED
STO
Dedicare's Year-end Report 1 January - 31 December 2024: Continued weak progress in the fourth quarter concluded a challenging 2024
News Preview
STOCKHOLM, Feb. 7, 2025 /PRNewswire/ -- Fourth quarter 2024
Net sales SEK 389.0 million (464.1)EBITA SEK 19.5 million (41.6), adjusted for non-recurring items SEK 12.8 million (30.7)EBITA margin 5.0 percent (9.0), adjusted for non-recurring items 3.3 percent (6.6)EBIT SEK 17.2 million (39.3), adjusted for non-recurring items SEK 10.6 million (28...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.02.2025
IBAB
LISTED
EURONEXT
Framatome and IBA to partner to develop an Astatine-211 Cyclotron Network in Europe and the USA
News Preview
Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.02.2025
GNFT
LISTED
EURONEXT
GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 6, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today outlines the design of new clinical trials within its Acute on-Chronic Liver Failure (ACL...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.02.2025
IBAB
LISTED
EURONEXT
IBA signs Proteus®ONE system contract with AIG in Hyderabad, India
News Preview
Louvain-La-Neuve, Belgium, February 06, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a binding agreement with the Asian Institute of Gastroenterology (AIG) for the supply o...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.02.2025
GN
LISTED
CPH
GN Annual Report 2024: Strong growth in Hearing and Gaming offset by slight decline in Enterprise leading to 1% Group organic revenue growth, 12% reported EBITA margin, and free cash flow excl. M&A of DKK 1.1 billion
News Preview
2024 highlights...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.02.2025
RXRX
LISTED
NASDAQ
Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
News Preview
SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) reported 12 month data from the Phase 2 study (SYCAMORE) of REC-994, the first industry sponsored Phase 2 trial completed in Cerebral Cavernous Malformations (CCM). The Company announced in September 2024 that the signal-finding study met its primary endpoint....
Themefolio
Profiler
Peergroup
© BusinessWire
05.02.2025
QGEN
LISTED
NYSE
QIAGEN delivers solid Q4 2024 growth ahead of outlook
News Preview
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced financial results for the fourth quarter and full-year 2024.
Net sales for Q4 2024 increased 2% to $521 million compared to Q4 2023, while sales at constant exchange rates (CER) of $525 million rose 3% and were above the outlook for at least $520 million CER and core sales (...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.02.2025
CHEMM
LISTED
CPH
Interim report 2024/25 - Solid H1 performance driven by growth in both revenue and earnings
News Preview
ANNOUNCEMENT NO. 2875 February 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
05.02.2025
SECT_B
LISTED
STO
Sectra keeps #1 position in customer satisfaction--earns 8 Best in KLAS awards within radiology and digital pathology
News Preview
LINKÖPING, Sweden and SHELTON, Conn., Feb. 5, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has won eight Best in KLAS awards for its enterprise imaging modules for radiology (Sectra PACS) and digital pathology. This marks 12 consecutive years that Sectra PACS has been ranked number one in cu...
Themefolio
Profiler
Peergroup
© PR Newswire
05.02.2025
SOBI
LISTED
STO
Sobi publishes Q4 2024 report: A solid ending to a strong year
News Preview
STOCKHOLM, Feb. 5, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2024.
Fourth Quarter 2024
Total revenue increased 9 per cent, 8 per cent at constant exchange rates, (CER)1, to SEK 7,436 M (6,844)Haematology revenue increased 22 per cent at CER to SEK 4,487 M (3,640), mainly dri...
Themefolio
Profiler
Peergroup
© PR Newswire
05.02.2025
SOBI
LISTED
STO
Sobi publishes Q4 2024 report: A solid ending to a strong year
News Preview
STOCKHOLM, Feb. 5, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2024.
Fourth Quarter 2024
Total revenue increased 9 per cent, 8 per cent at constant exchange rates, (CER)1, to SEK 7,436 M (6,844)Haematology revenue increased 22 per cent at CER to SEK 4,487 M (3,640), mainly dri...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.02.2025
FYB
LISTED
XETR
Lotus Pharmaceutical wird strategischer Vermarktungspartner für Formycons Eylea®-Biosimilar FYB203/AHZANTIVE® in der Asien-Pazifik-Region
News Preview
Pressemitteilung // 5. Februar 2025
Lotus Pharmaceutical wird strategischer Vermarktungspartner für Formycons Eylea®-Biosimilar FYB203/AHZANTIVE® in der Asien-Pazifik-Region
Planegg-Martinsried – Klinge Biopharma GmbH („Klinge”), Lizenznehmer und exklusiver Inhaber der weltweiten Vermarktungsrechte für FYB203/AHZANTIVE®1 (Aflibercept), Formyc......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.02.2025
FYB
LISTED
XETR
Lotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region
News Preview
Press Release // February 05, 2025
Lotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region
Planegg-Martinsried, Germany – Klinge Biopharma GmbH (“Klinge”), the exclusive owner of the global commercialization rights of FYB203/AHZANTIVE®1 (aflibercept......
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2025
QGEN
LISTED
NYSE
QIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent
News Preview
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the German Federal Patent Court (Bundespatentgericht) has ruled in its favor in a patent dispute against SD Biosensor, reaffirming the validity of an important patent protecting key innovations in its QuantiFERON technology.
This ruling underscores the strength of QIAGE...
Themefolio
Profiler
Peergroup
© EQS Newswire
04.02.2025
1SXP
LISTED
XETR
Shareholders approve all agenda items
News Preview
SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items
SCHOTT Pharma held its Annual General Meeting virtually on February 4, 2025
All items on the agenda were approved by shareholders
Dr. Wolfram Carius has been appointed to SCHOTT Pharma’s Supervisory Board, replacing Dr. Wolfgang Wienand
SCHOTT Pharma, ......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.02.2025
1SXP
LISTED
XETR
SCHOTT Pharma mit erfolgreicher Hauptversammlung – Aktionärinnen und Aktionäre stimmen allen Tagesordnungspunkten zu
News Preview
SCHOTT Pharma mit erfolgreicher Hauptversammlung – Aktionärinnen und Aktionäre stimmen allen Tagesordnungspunkten zu
SCHOTT Pharma hat am 4. Februar 2025 seine ordentliche Hauptversammlung virtuell abgehalten
Aktionärinnen und Aktionäre stimmten allen Tagesordnungspunkten zu
Dr. Wolfram Carius wurde als Nachfolger von Dr. Wolfgang Wienand in de......
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2025
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Informations relatives au nombre total de droits de vote et d’actions composant le capital...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2025
SLP
LISTED
NASDAQ
Simulations Plus to Participate in Upcoming Healthcare Investor Conferences
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it will participate in two healthcare investor conferences in February.
The Company is attend...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2025
DFTX
LISTED
NASDAQ
MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference:
Oppenheimer 35th Annu...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2025
COLO B
LISTED
CPH
Coloplast A/S - Allocation of Share Options
News Preview
Report on transactions of executives and related parties in Coloplast shares and related securities...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2025
COLO B
LISTED
CPH
Coloplast A/S - Interim Financial Report, Q1 2024/25
News Preview
2024/25...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2025
FAGR
LISTED
EURONEXT
Fagron solidifies its leadership position with the acquisition of Guinama in Spain
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 4 Feb 2025 – 7AM CET...
Themefolio
Profiler
Peergroup
© BusinessWire
03.02.2025
TEM
LISTED
NASDAQ
Tempus Completes Acquisition of Ambry Genetics
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics, a recognized leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease.
“This acquisition com...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.02.2025
ANAB
LISTED
NASDAQ
Anaptys to Present at the Guggenheim SMID Cap Biotech Conference
News Preview
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, will present at the Guggenheim SMID Cap Biotech Conference on Wednesday, Feb. 5, 2025 at...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.02.2025
BAVA
LISTED
CPH
Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded Guidance and Guides for 2025
News Preview
COPENHAGEN, Denmark, February 3, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced preliminary, unaudited financial results for 2024 and provided its financial guidance for 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.02.2025
SN
LISTED
LSE
Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes
News Preview
Healthcare professionals are invited to register for the livestream option as a courtesy here...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.02.2025
EUZ
LISTED
XETR
IT Incident Affects Eckert & Ziegler SE's Communication Channels
News Preview
Press Release
IT Incident Affects Eckert & Ziegler SE's Communication Channels
Berlin, 03 February 2025. Due to an unexpected IT incident, Eckert & Ziegler is currently unable to receive emails or phone calls. We understand the inconvenience this may cause and want to assure our customers and partners that we are working diligently to ......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.02.2025
EUZ
LISTED
XETR
IT-Vorfall beeinträchtigt die Kommunikationskanäle der Eckert & Ziegler SE
News Preview
Pressemitteilung
IT-Vorfall beeinträchtigt die Kommunikationskanäle der Eckert & Ziegler SE
Berlin, 03. Februar 2025. Aufgrund eines unerwarteten IT-Vorfalls ist Eckert & Ziegler derzeit weder per E-Mail noch telefonisch erreichbar. Wir verstehen die Unannehmlichkeiten, die dies verursachen kann, und möchten unsere Kunden und Partner ve......
Themefolio
Profiler
Peergroup
© Globe Newswire
31.01.2025
BAVA
LISTED
CPH
Bavarian Nordic – Completion of Share Buy-Back Program
News Preview
COPENHAGEN, Denmark, January 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on January 9, 2025, has now been completed, reaching an aggregate amount of approximately DKK 150 million as planned. Bavarian Nordic will hold the shares bought back as treasury stock, for the purpose...
Themefolio
Profiler
Peergroup
© ActuNews
31.01.2025
ALTHX
LISTED
EURONEXT
THERANEXUS : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
News Preview
Lyon, France – 31 janvier 2025, 18h00 CET – Theranexus, société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, publie aujourd'hui le bilan semestriel de son contrat de liquidité confié à Portzamparc.
Au titre du contrat de liquidité confié par la soci...
Themefolio
Profiler
Peergroup
© PR Newswire
31.01.2025
BIOA B
LISTED
STO
Update on regulatory review of lecanemab for treatment of early Alzheimer's disease in the European Union
News Preview
STOCKHOLM, Jan. 31, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee for Medicinal Products for Human Use (CHMP) to consider two additional questions. These questions will now be discussed at the CHMP meeting in February 2025, before the Commis...
Themefolio
Profiler
Peergroup
© PR Newswire
31.01.2025
BIOA B
LISTED
STO
Update on regulatory review of lecanemab for treatment of early Alzheimer's disease in the European Union
News Preview
STOCKHOLM, Jan. 31, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee for Medicinal Products for Human Use (CHMP) to consider two additional questions. These questions will now be discussed at the CHMP meeting in February 2025, before the Commis...
Themefolio
Profiler
Peergroup
© PR Newswire
31.01.2025
IMMNOV
LISTED
STO
Change in number of shares and votes in Immunovia AB (publ)
News Preview
LUND, Sweden, Jan. 31, 2025 /PRNewswire/ -- During January 2025, the registered number of shares and votes in Immunovia AB (publ) ("Immunovia") has increased due exercise of warrants of series TO 2. As of 31 January 2025, the registered number of shares and votes in Immunovia amounts to 261,908,863.
For further information, please contactJeff Bo...
Themefolio
Profiler
Peergroup
© PR Newswire
31.01.2025
IMMNOV
LISTED
STO
Change in number of shares and votes in Immunovia AB (publ)
News Preview
LUND, Sweden, Jan. 31, 2025 /PRNewswire/ -- During January 2025, the registered number of shares and votes in Immunovia AB (publ) ("Immunovia") has increased due exercise of warrants of series TO 2. As of 31 January 2025, the registered number of shares and votes in Immunovia amounts to 261,908,863.
For further information, please contact:Jeff B...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.01.2025
BAVA
LISTED
CPH
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
News Preview
COPENHAGEN, Denmark, January 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization for VIMKUNYA® (CHIKV VLP vaccine) for active immunization for the prevention of disease caus...
Themefolio
Profiler
Peergroup
© BusinessWire
30.01.2025
EHAB
LISTED
NYSE
Enhabit Home Health & Hospice Earns 2025 Great Place To Work Certification™
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, announced today that it is proud to be Certified™ by Great Place To Work®. This prestigious award is based entirely on the experiences of current employees working at Enhabit. This year, 83% of employees said it’s a great place to work, which is 26 points higher than the avera...
Themefolio
Profiler
Peergroup
© ActuNews
30.01.2025
ALTHX
LISTED
EURONEXT
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2024 AND PRESENTS ITS PROGRESS REPORT
News Preview
Lyon, France – 30 January 2025, 6pm CET – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, today announces publication of its cash position as at 31 December 2024, and presents its progress report.
On 31 December 2024, total available funds stood at €1.0 M, compared with&n...
Themefolio
Profiler
Peergroup
© ActuNews
30.01.2025
ALTHX
LISTED
EURONEXT
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 31 DÉCEMBRE 2024 ET FAIT LE POINT SUR SES ACTIVITÉS
News Preview
Lyon, France – 30 janvier 2025, 18h00 CET - Theranexus, société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, annonce aujourd'hui la publication de sa position de trésorerie au 31 décembre 2024 et fait le point sur ses activités.
Au 31 décembre 2024, la tré...
Themefolio
Profiler
Peergroup
© BusinessWire
30.01.2025
ICLR
LISTED
NASDAQ
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI) tools that deliver efficiencies across the clinical trial process, including study startup, document management, resource forecasting and metrics reporting.
ICO...
Themefolio
Profiler
Peergroup
© BusinessWire
30.01.2025
DFTX
LISTED
NASDAQ
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that the first patient has been dosed in Panorama, its second Phase 3 study evaluating MM120 ODT, a proprietary, pharmaceutically optimized f...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.01.2025
KDEV
LISTED
STO
Karolinska Development’s portfolio company Dilafor advances tafoxiparin following successful meetings with FDA and European regulatory authorities
News Preview
STOCKHOLM, SWEDEN – January 30, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has successfully completed regulatory meetings with the U.S. Food and Drug Administration, FDA, and European Health Agencies, regarding the continued development of the company’s drug candidate tafoxiparin. The...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.01.2025
GNFT
LISTED
EURONEXT
GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 30, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases (the “Company”), today announces that it has entered into a non-dilutive capped royal...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.01.2025
GNFT
LISTED
EURONEXT
GENFIT Announces 2025 Financial Calendar
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 29, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its provisional financial calendar for 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.01.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy
News Preview
OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
